The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.
Here is an updated overview of the role of BCMA-directed therapies following the 2024 ASCO Annual Meeting and EHA Congress.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
An overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.
Access to birth control is a crucial part of preventive health care, but financial barriers persist
Experts share final thoughts and advice for clinicians in the community to help optimize treatment success in CLL.
Many studies with a stated goal of advancing child health care in administratively-defined minors have no clinical value and may even harm young patients.
Creating additional space for nursing mothers can be challenging in small pharmacies
Older adults without a Part D plan face costs ranging from $180 to $295 per shot.
The 5 largest specialty therapeutic groups—oncology, autoimmune, immunology, HIV, and multiple sclerosis—will account for 74% of specialty spending growth over the next five years.
Cross-border collaborations are the way forward to make life-saving treatments more affordable and accessible to patients with rare diseases around the world.
Collaboration and knowledge sharing amongst rare disease researchers can be difficult, as these researchers are often spread out throughout the world.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Understanding causes, consequences proves vital to develop therapies that exploit vulnerabilities of the cancer cells.
The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.
Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.
Black women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.
Rare disease specialty pharmacies offer customizable pharmacy and patient services to make it easier for people living with rare, complex, and often isolating conditions to access the therapy, care, and resources they need.
Vaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
The use of high throughput technologies has revolutionized the understanding of the cancer genome.
Students are being exposed to new patient experiences through collaboration with practitioners.
Pharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Additional support is necessary to ensure that infrastructure development continues and that all pharmacists have the necessary tools to continue to provide immunization services.
Axatilimab-csfr is a colony-stimulating factor-1 receptor (CSFR1) blocking monoclonal antibody indicated for cGVHD after 2 or more lines of prior therapy in adults and pediatric patients that weigh at least 40 kg.
Patients may consult with their pharmacist regarding appropriate protection methods and treatment options available for common summer skin ailments.
Original biologic products, and more recently biosimilar products, are a groundbreaking advancement in modern medical treatments. Pharmacists should understand biologic products and concerns with biosimilars.